Clarity Capital Partners’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,530
Closed -$201K 124
2023
Q4
$201K Buy
+3,530
New +$201K 0.14% 110